A Phase 3 pivotal trial, co-led by IDDO/WWARN scientist Dr Mehul Dhorda, has begun to evaluate a novel fixed-dose triple artemisinin-based combination treatment (FD-TACT) for uncomplicated Plasmodium falciparum malaria.

Professor Joel Tarning, Lead of WWARN’s Malaria Pharmacometrics Theme, has been honoured with the award of the Royal Society of Tropical Medicine and Hygiene’s Chalmers Medal for his exceptional contribution to the field of clinical pharmacology of neglected tropical diseases, and in particular anti...

A new study has found the current recommended treatment for Chagas disease could be given over a substantially shorter time period and still be as effective.

Greater surveillance and well-designed epidemiological studies for noma should be a research priority, a new study recommends.

Researchers say it’s “crucial” to develop a child-friendly, affordable primaquine formulation to support global malaria elimination efforts and limit the spread of drug-resistant malaria.

IDDO’s malaria data hub, the WorldWide Antimalarial Resistance Network, has launched five themes that form a focus for its expanding research on monitoring resistance and maximising the efficacy of current and new antimalarial drugs.

Researchers at the Medicine Quality Research Group, University of Oxford and collaborators, including the Serum Institute of India, have published an innovative method to identify falsified vaccines without opening the vaccine vial.

A new study has found methaemoglobin levels during treatment for vivax malaria could be used to predict whether a patient would have recurrent malaria.

The Medicine Quality Research Group invited to present at the World Health Summit Dr Gesa Gnegel and Dr Céline Caillet were invited to present their current work during a session at the World Health Summit Berlin, Germany, on October 15.

Join IDDO and WWARN’s researchers at this year’s American Society of Tropical Medicine & Hygiene (ASTMH) in where we will be presenting on Visceral Leishmaniasis, malaria, COVID-19 and across symposia, oral presentations and posters.

Experts from across Europe joined forces to discuss research on substandard and falsified medical products and how to translate the evidence into policy and implementation.

A new study which will help inform World Health Organization guidelines for treating children with Plasmodium vivax malaria has found that giving children higher doses of primaquine substantially reduced recurrences of malaria.

Collaborators of a multi-country project aimed at better understanding the impact, origin and trade routes of falsified medical products gathered to share updates and make final year plans.

IDDO and the Global Research on Antimicrobial Resistance (GRAM) Project are delighted to announce the first antimicrobial resistance (AMR) dataset is now available to reuse for further research.

A new systematic review, published in the American Journal of Tropical Medicine & Hygiene, summarises the heterogeneity in design and analysis of clinical trials for visceral leishmaniasis (VL) – information which can potentially help improve future trial designs.

Nominations for new IDDO Data Access Committee (DAC) members are now open. Please nominate individuals with expertise in Chagas Disease, Antimicrobial Resistance or visceral leishmaniasis to dataaccess@iddo.org.

A new review summarises existing evidence gaps regarding when blood transfusions should be carried out for visceral leishmaniasis patients. The review is published in Transactions of the Royal Society of Tropical Medicine and Hygiene.